These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10261790)

  • 1. Other viewpoints on the effects of cost controls.
    Davis NM
    Hosp Pharm; 1983 Aug; 18(8):400-5, 409. PubMed ID: 10261790
    [No Abstract]   [Full Text] [Related]  

  • 2. Hospital cost controls will stifle new drug technology.
    Hoffmann RP
    Hosp Pharm; 1983 Aug; 18(8):397. PubMed ID: 10261789
    [No Abstract]   [Full Text] [Related]  

  • 3. Hospital pharmacy in 1990: the year in review.
    Nold EG
    Am J Hosp Pharm; 1991 Apr; 48(4):720-30. PubMed ID: 2042673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospital policies on pharmaceutical sales representatives' activities.
    Oddis JA
    Resid Staff Physician; 1987 Sep; 33(10):8. PubMed ID: 10284382
    [No Abstract]   [Full Text] [Related]  

  • 5. Biotech on the brink.
    Taylor KS
    Hosp Health Netw; 1993 Sep; 67(17):36, 38. PubMed ID: 8353563
    [No Abstract]   [Full Text] [Related]  

  • 6. A commentary on high-cost drugs.
    de Leon RF
    Curr Concepts Hosp Pharm Manage; 1989; 11(3):4-7. PubMed ID: 10318277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of pharmaceutical services in cost containment.
    Jordan D
    Hosp Mater Manage Q; 1980 Feb; 1(3):49-61. PubMed ID: 10316932
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical pharmacy and the pharmaceutical industry.
    Ruggiero JS
    Am J Hosp Pharm; 1973 Apr; 30(4):311-5. PubMed ID: 4697654
    [No Abstract]   [Full Text] [Related]  

  • 9. Biotechnology partnerships--medicine for an ailing industry?
    DeLamarter J
    Nat Biotechnol; 2003 Aug; 21(8):847-8. PubMed ID: 12894192
    [No Abstract]   [Full Text] [Related]  

  • 10. Researchers reconsider plants as drug sources.
    Souhrada L
    Hospitals; 1989 Mar; 63(5):34. PubMed ID: 2917751
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug firms' woes may slow profit growth.
    Dine DD
    Mod Healthc; 1989 Feb; 19(7):52. PubMed ID: 10291927
    [No Abstract]   [Full Text] [Related]  

  • 12. Private company profiles.
    Nat Biotechnol; 2002 Jul; 20 Suppl():BE15-21. PubMed ID: 12089572
    [No Abstract]   [Full Text] [Related]  

  • 13. Opportunities in high technology.
    Anderson RW
    Am J Hosp Pharm; 1986 Apr; 43(4):903. PubMed ID: 3706333
    [No Abstract]   [Full Text] [Related]  

  • 14. Annual pharmaceutical manufacturers directory--1992.
    Canizares E
    Hosp Pharm; 1992 Jan; 27(1):23-4, 26, 28-30. PubMed ID: 10116119
    [No Abstract]   [Full Text] [Related]  

  • 15. What key role can hospital RPhs play in cost control?
    Lapp RJ
    Pharm Times; 1986 May; 52(5):51-4, 57. PubMed ID: 10277224
    [No Abstract]   [Full Text] [Related]  

  • 16. The untapped segment of the pharmaceutical marketplace.
    Caraccioli K
    Med Mark Media; 1980 Aug; 15(8):23-9. PubMed ID: 10248107
    [No Abstract]   [Full Text] [Related]  

  • 17. Hospital pharmacies respond to cost-containment pressures.
    Oddis JA
    Resid Staff Physician; 1987 Feb; 33(2):11, 14. PubMed ID: 10281133
    [No Abstract]   [Full Text] [Related]  

  • 18. What new Rx services were implemented by hospitals in the 1980s?
    Lantos RL
    Pharm Times; 1987 Jan; 53(1):64-8. PubMed ID: 10280507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three surefire ways to cut your pharmacy costs.
    Capitation Manag Rep; 2001 Jan; 8(1):1-7. PubMed ID: 11209215
    [No Abstract]   [Full Text] [Related]  

  • 20. Tips and techniques: controlling drug costs.
    Gallina JN
    Curr Concepts Hosp Pharm Manage; 1988; 10(3):13. PubMed ID: 10288228
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.